Personalized cancer T-cell therapy takes the stage, mirroring vaccine success.
Détails
Télécharger: 38861029.pdf (1155.31 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-SA 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-SA 4.0
ID Serval
serval:BIB_CEA5DB463B31
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Personalized cancer T-cell therapy takes the stage, mirroring vaccine success.
Périodique
The Journal of experimental medicine
ISSN
1540-9538 (Electronic)
ISSN-L
0022-1007
Statut éditorial
Publié
Date de publication
05/08/2024
Peer-reviewed
Oui
Volume
221
Numéro
8
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Personalized T-cell therapy is emerging as a pivotal treatment of cancer care by tailoring cellular therapies to individual genetic and antigenic profiles, echoing the exciting success of personalized vaccines. We describe here the parallel evolution and analogies of cancer vaccines and T-cell therapies.
Mots-clé
Animals, Humans, Cancer Vaccines/immunology, Cell- and Tissue-Based Therapy/methods, Immunotherapy/methods, Neoplasms/therapy, Neoplasms/immunology, Precision Medicine/methods, T-Lymphocytes/immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/06/2024 13:47
Dernière modification de la notice
26/07/2024 6:01